Germinoma
5
3
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
Molecular Epidemiology of Pediatric Germ Cell Tumors
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology